Create Medic Co., Ltd. (TYO:5187)
1,159.00
-1.00 (-0.09%)
Mar 13, 2026, 3:30 PM JST
Create Medic Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 5,830 | 6,317 | 4,392 | 4,305 | 4,359 |
Cash & Short-Term Investments | 5,830 | 6,317 | 4,392 | 4,305 | 4,359 |
Cash Growth | -7.71% | 43.83% | 2.02% | -1.24% | 9.72% |
Receivables | 3,330 | 3,157 | 3,424 | 3,518 | 3,552 |
Inventory | 4,487 | 3,921 | 4,314 | 3,848 | 3,218 |
Other Current Assets | 575 | 545 | 592 | 457 | 446 |
Total Current Assets | 14,222 | 13,940 | 12,722 | 12,128 | 11,575 |
Property, Plant & Equipment | 4,709 | 4,843 | 5,389 | 5,162 | 5,080 |
Long-Term Investments | 706 | 660 | 495 | 610 | 459 |
Other Intangible Assets | 418 | 532 | 565 | 636 | 686 |
Long-Term Deferred Tax Assets | 86 | 71 | 85 | 327 | 274 |
Other Long-Term Assets | 2 | 1 | 2 | 2 | 1 |
Total Assets | 20,143 | 20,047 | 19,258 | 18,865 | 18,075 |
Accounts Payable | 700 | 783 | 787 | 806 | 683 |
Accrued Expenses | 68 | 65 | 68 | 114 | 74 |
Short-Term Debt | - | 800 | 800 | 800 | 800 |
Current Income Taxes Payable | 66 | 83 | 84 | 129 | 118 |
Other Current Liabilities | 1,189 | 1,374 | 1,228 | 967 | 898 |
Total Current Liabilities | 2,023 | 3,105 | 2,967 | 2,816 | 2,573 |
Long-Term Debt | 749 | - | - | - | - |
Pension & Post-Retirement Benefits | 602 | 836 | 1,004 | 1,136 | 1,202 |
Long-Term Deferred Tax Liabilities | 354 | 261 | 216 | - | - |
Other Long-Term Liabilities | 84 | 95 | 128 | 190 | 80 |
Total Liabilities | 3,812 | 4,297 | 4,315 | 4,142 | 3,855 |
Common Stock | 1,461 | 1,461 | 1,461 | 1,461 | 1,461 |
Additional Paid-In Capital | 1,486 | 1,486 | 1,486 | 1,486 | 1,486 |
Retained Earnings | 11,476 | 11,078 | 10,586 | 10,871 | 10,931 |
Treasury Stock | -1,197 | -1,003 | -506 | -509 | -513 |
Comprehensive Income & Other | 3,105 | 2,728 | 1,916 | 1,414 | 855 |
Shareholders' Equity | 16,331 | 15,750 | 14,943 | 14,723 | 14,220 |
Total Liabilities & Equity | 20,143 | 20,047 | 19,258 | 18,865 | 18,075 |
Total Debt | 749 | 800 | 800 | 800 | 800 |
Net Cash (Debt) | 5,081 | 5,517 | 3,592 | 3,505 | 3,559 |
Net Cash Growth | -7.90% | 53.59% | 2.48% | -1.52% | 15.51% |
Net Cash Per Share | 575.44 | 625.97 | 394.63 | 385.25 | 391.31 |
Filing Date Shares Outstanding | 8.39 | 8.57 | 9.06 | 9.1 | 9.09 |
Total Common Shares Outstanding | 8.39 | 8.59 | 9.1 | 9.1 | 9.09 |
Working Capital | 12,199 | 10,835 | 9,755 | 9,312 | 9,002 |
Book Value Per Share | 1945.62 | 1833.59 | 1641.44 | 1618.03 | 1563.52 |
Tangible Book Value | 15,913 | 15,218 | 14,378 | 14,087 | 13,534 |
Tangible Book Value Per Share | 1895.82 | 1771.66 | 1579.38 | 1548.13 | 1488.09 |
Order Backlog | - | 535.03 | 551.39 | 593.32 | 473.06 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.